HPB & Spleen · 8 November 2023

Frailty’s Alarming Impact on Pancreatic Cancer Survival

This systematic review and meta-analysis delved into the world of pancreatic cancer, focusing on frailty. Among 35,191 patients, they discovered that 45% of pancreatic cancer patients were frail. This frailty took a toll, significantly reducing their chances of survival. While the results displayed some variation, they underscored the vital role of assessing frailty in pancreatic cancer cases, offering valuable insights for prognosis and decision-making.

Journal Article by Zhang F, Yan Y and Ge C in Ann Surg Oncol

read the whole article in Ann Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Ann Surg Oncol2 Nov 2026

Pancreatic ductoscopy guides tissue preservation

In two older patients having robotic surgery for a pancreatic growth, ductoscopy and checks of the cut edge let surgeons leave the remaining pancreas in place.

HPB & Spleen30 Oct 2026

Intrahepatic cholangiocarcinoma has more options

Resection remains central, but care now includes preoperative therapy, liver-directed treatments and drugs matched to tumor changes.

Ann Surg Oncol29 Oct 2026

Pancreatic cancer: longer survival with combined treatment

For locally advanced pancreatic cancer, cryoablation plus drug treatment was linked to longer median survival than drug treatment alone, but the result does not prove benefit.

All papers in HPB & Spleen →